CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-09 | Guyer William Chief Development Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-02-09 | Lyon Joseph Douglas Chief Accounting Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2024-02-09 | Hunt Hazel Chief Scientific Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-02-09 | Mokari Atabak Chief Financial Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-02-09 | Robb Gary Charles Chief Business Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-02-01 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $5.86 | $13K | 2,200 |
| 2024-02-01 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $22.00 | $48K | 0 |
| 2024-02-01 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 11,150 | ||
| 2024-01-08 | Hunt Hazel Chief Scientific Officer | Option exercise | +50,000 | $3.02 | $151K | 123,146 |
| 2024-01-08 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −29,792 | $27.46 | $818K | 93,354 |
| 2024-01-08 | Hunt Hazel Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −50,000 | 0 | ||
| 2024-01-02 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $5.86 | $13K | 2,200 |
| 2024-01-02 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $22.11 | $49K | 0 |
| 2024-01-02 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 13,350 | ||
| 2023-12-22 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +10,000 | $19.26 | $193K | 16,643 |
| 2023-12-22 | Guyer William Chief Development Officer | Sale 10b5-1 | −10,000 | $32.00 | $320K | 6,643 |
| 2023-12-22 | Guyer William Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 90,000 | ||
| 2023-12-15 | Robb Gary Charles Chief Business Officer | Gift | −750 | 20,640 | ||
| 2023-12-13 | Robb Gary Charles Chief Business Officer | Other disposition | −1,000 | 7,700 | ||
| 2023-12-08 | Robb Gary Charles Chief Business Officer | Gift | +639 | 8,700 |
Page 43 of 61 · 1,220 trades